Not from Advocate Aurora Health? Click the title link for additional options to access full-text. For best viewing, we recommend Google Chrome.


Works from 2020


Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh-frozen plasma, Mehraboon S. Irani, Federico Sanchez, and Kenneth Friedman (Article)


Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy, Meha Bhatt, Cody Braun, Payal Patel, Parth Patel, Housne Begum, Wojtek Wiercioch, Jamie Varghese, David Wooldridge, Hani J Alturkmani, Merrill Thomas, Mariam Baig, Waled Bahaj, Rasha Khatib, Rohan Kehar, Rakesh Ponnapureddy, Anchal Sethi, Ahmad Mustafa, Robby Nieuwlaat, Wendy Lim, Shannon M Bates, Eddy Lang, Grégoire Le Gal, Marc Righini, Nedaa M Husainat, Mohamad A Kalot, Yazan Nayif Al Jabiri, Holger J Schünemann, and Reem A Mustafa (Article)


Has the time come to implement gene therapy for sickle cell disease?, Norman Ginsberg and Lee P Shulman (Article)


Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry, Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, Michael A. Thompson, David L. Grinblatt, Daniel A. Pollyea, Rami Komrokji, Gail J. Roboz, Michael R. Savona, Mikkael A. Serkeres, E Dawn Flick, Pavel Kiselev, Chrystal U. Louis, Melissa Nifenecker, Arlene S. Swern, Harry P. Erba, David P. Steensma, and Bart L. Scott (Abstract)

Works from 2019


Anticoagulation RNs will demonstrate competence and consistency in practice, Adrianne Waters-Fechter (Poster)


Ibrutinib and rituximab provides superior clinical outcome compared to FCR in younger patients with chronic lymphocytic leukemia (CLL): Extended follow-up from the E1912 trial, Tait D Shanafelt, Victoria Wang, Neil E Kay, Curtis A Hanson, Susan M O'Brien, Jacqueline C Barrientos, Diane F Jelinek, Esteban Braggio, Jose F Leis, Cong Christina Zhang, Steven Coutre, Paul M Barr, Amanda F Cashen, Anthony R Mato, Avina Singh, Michael P. Mullane, Richard F Little, Harry P Erba, Richard M Stone, Mark Litzow, and Martin S Tallman (Article)


Ibrutinib-rituximab or chemoimmunotherapy for chronic lymphocytic leukemia, Tait D Shanafelt, Xin V Wang, Neil E Kay, Curtis A Hanson, Susan O'Brien, Jacqueline Barrientos, Diane F Jelinek, Esteban Braggio, Jose F Leis, Cong C Zhang, Steven E Coutre, Paul M Barr, Amanda F Cashen, Anthony R Mato, Avina K Singh, Michael P. Mullane, Richard F Little, Harry Erba, Richard M Stone, Mark Litzow, and Martin Tallman (Article)


INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma, Caitlin Costello, Faith E Davies, Gordon Cook, Jorge Vela-Ojeda, Jim Omel, Robert M Rifkin, Jesus Berdeja, Noemi Puig, Saad Z Usmani, Katja Weisel, Jeffrey A Zonder, Evangelos Terpos, Andrew Spencer, Xavier Leleu, Mario Boccadoro, Michael A. Thompson, Dorothy Romanus, Dawn M Stull, and Vania Hungria (Article)


Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia, Mehraboon Irani, Eric Siegal, Abhay Jella, Richard Aster, and Anand Padmanabhan (Article)

Works from 2018


A global treatment standard in multiple myeloma (MM) remains elusive despite advances in care over 15 years: first results from INSIGHT MM, the largest global prospective, observational MM study, Caitlin L. Costello, Mario Boccadoro, Michael A. Thompson, and et al (Abstract)


American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, Daniel M Witt, Robby Nieuwlaat, Nathan P Clark, Jack Ansell, Anne Holbrook, Jane Skov, Nadine Shehab, Juliet Mock, Tarra Myers, Francesco Dentali, Mark A Crowther, Arnav Agarwal, Meha Bhatt, Rasha Khatib, John J Riva, Yuan Zhang, and Gordon Guyatt (Article)


Contemporary risk factors and outcomes of transfusion-associated circulatory overload, Nareg H Roubinian, Jeanne E Hendrickson, Darrell J Triulzi, Jerome L Gottschall, Michael Michalkiewicz, Dhuly Chowdhury, Daryl J Kor, Mark R Looney, Michael A Matthay, Steven H Kleinman, Donald Brambilla, and Edward L Murphy (Article)


Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome, Matthew Walters, Mark R Pittelkow, Robert P Hasserjian, Nancy Lee Harris, William R Macon, Paul J Kurtin, and Karen L G Rech (Article)

Works from 2017

A report of cerebral malaria treated with automated red blood cell exchange, Waseem Q Anani, Gerald P. Smith, Mehraboon Irani, and Kathleen E Puca (Article)


Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response, Michael A. Thompson, Martin K. Oaks, Maharaj Singh, Karen M. Michel, Michael P. Mullane, Husam S. Tarawneh, Angi Kraut, and Kayla J. Hamm (Brief Report)


Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study, Andinet Alemu, Maharaj Singh, Chris Blumberg, John O. Richards, Martin K. Oaks, and Michael A. Thompson (Original Research)

Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells, Mehraboon S Irani, Matthew S Karafin, and Luke Ernster (Case Report)

Works from 2016

Comparison of ε-aminocaproic acid and tranexamic acid in reducing post-operative transfusions in total hip arthroplasty, Jessica L. Churchill, Kathleen E. Puca, Elizabeth S. Meyer, Matthew C. Carleton, Susan L. Truchan, and Michael J. Anderson (Abstract)

En bloc Liver kidney transplantation using donor splenic artery as inflow to the kidney. Report of two cases, Vikraman Gunabushanam, Jacob Clendenon, Erika Aldag, Manpreet Chadha, David Kramer, Jeffery Steers, and Ajay Sahajpal (Article)


Evaluation of Preoperative Anemia and Transfusion Requirements in Adult Liver Transplant Recipients, Parissa Moghimi, Erika Aldag, Rachel Pedersen, Ajay Sahajpal, Jacob Clendenon, Vikraman Gunabushanam, Mehraboon S. Irani, and David Kramer (Poster)

Social media and internet resources for patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn), Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, and Andrew A. Lane (Article)

Social media and myeloproliferative neoplasms (mpn): analysis of advanced metrics from the first year of a new twitter community: #mpnsm, Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Jean-Jacques Kiladjian, Ruben Mesa, and Michael A. Thompson (Article)

Works from 2015

‘Everyone is an individual’: providing individualized treatment in oncology, Michael A. Thompson (Article)

Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells: 54, Mehraboon S. Irani, Luke Ernster, and Matthew Karafin (Abstract)

Social Media and the practicing hematologist: Twitter 101 for the busy healthcare provider, Michael A. Thompson, Navneet S Majhail, William A Wood, Miguel-Angel Perales, and Mélanie Chaboissier (Article)

Works from 2012

Flow cytometry assessment of residual melanoma cells in tumor-infiltrating lymphocyte cultures, John O. Richards, Jonathan Treisman, Nina Garlie, John P. Hanson, and Martin Oaks (Article)

Works from 2009

Biochemical analysis of CTLA-4 immunoreactive material from human blood, Matt Tector, Bhupendra O Khatri, Karen Kozinski, Kate Dennert, and Martin Oaks (Article)

Works from 2008

Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms, Andrew Berry, Matt Tector, and Martin Oaks (Article)